Emerging immunotherapy in pediatric lymphoma.

Erker, Craig; Harker-Murray, Paul; Burke, Michael J

Erker, Craig; Harker-Murray, Paul; Burke, Michael J.

Affiliation

Erker C; Division of Pediatric Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Harker-Murray P; Division of Pediatric Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Burke MJ; Division of Pediatric Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

Future Oncol ; 12(2): 257-70, 2016 Jan.

Article in En | MEDLINE | ID: mdl-26616565

Subject(s)

Immunotherapy; Lymphoma/immunology; Lymphoma/therapy; Adolescent; Antibodies, Monoclonal/pharmacology; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cell- and Tissue-Based Therapy; Child; Child, Preschool; Genetic Therapy; Humans; Immunomodulation/drug effects; Immunotherapy/methods; Immunotoxins/pharmacology; Immunotoxins/therapeutic use; Infant; Infant, Newborn; Molecular Targeted Therapy; T-Lymphocytes/immunology; T-Lymphocytes/metabolism; T-Lymphocytes/transplantation

Key words

Hodgkin lymphoma; checkpoint inhibitors; immunotherapy; non-Hodgkin lymphoma; pediatric

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy / Lymphoma Limits: Adolescent / Child / Child, preschool / Humans / Infant / Newborn Language: En Journal: Future Oncol Year: 2016 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google